Eastwood Bio-Medical Canada Inc Total Assets
Eastwood Bio-Medical Canada Inc total assets. Based on the latest financial reports, Eastwood Bio-Medical Canada Inc (EBM) holds total assets worth CA$265.38K CAD (≈ $191.97K USD) as of April 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Eastwood Bio-Medical Canada Inc stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Eastwood Bio-Medical Canada Inc (2013–2025)
Total assets of Eastwood Bio-Medical Canada Inc from 2013 to 2025. This chart illustrates how Eastwood Bio-Medical Canada Inc's total assets have evolved over time, based on quarterly financial data. See EBM stock price and chart for real-time trading data and today's change.
Eastwood Bio-Medical Canada Inc - Asset Composition Analysis
Eastwood Bio-Medical Canada Inc Total Assets Breakdown (October 2025)
Eastwood Bio-Medical Canada Inc total assets breakdown as of October 2025. Eastwood Bio-Medical Canada Inc's total assets of CA$265.38K consist of 15.1% current assets and 84.9% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 8.1% |
| Accounts Receivable | CA$14.62K | 6.7% |
| Inventory | CA$0.00 | 0.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Eastwood Bio-Medical Canada Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Eastwood Bio-Medical Canada Inc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Eastwood Bio-Medical Canada Inc's current assets represent 15.1% of total assets in 2025, a decrease from 100.0% in 2013.
- Cash Position: Cash and equivalents constituted 8.1% of total assets in 2025, up from 0.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 6.7% of total assets.
Eastwood Bio-Medical Canada Inc Competitors by Total Assets
Key competitors of Eastwood Bio-Medical Canada Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $10.03 Billion |
|
Pharmaron Beijing Co Ltd
SHE:300759
|
China | CN¥25.80 Billion |
|
PHARVARIS N.V. EO -12
F:9EN
|
Germany | €301.45 Million |
|
GH RESEARCH PLC DL-025
F:1KA
|
Germany | €372.35 Million |
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
USA | $400.37 Million |
|
Savara Inc
NASDAQ:SVRA
|
USA | $192.14 Million |
|
INVENTIVA ADS/1 O.N.
F:6IVA
|
Germany | €249.51 Million |
|
Innovita Biological Technology Co. Ltd. A
SHG:688253
|
China | CN¥2.23 Billion |
Eastwood Bio-Medical Canada Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.05 | 0.03 | 0.19 |
| Quick Ratio | 0.05 | 0.03 | 0.19 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-1.88 Million | CA$-1.68 Million | CA$-613.95K |
Eastwood Bio-Medical Canada Inc - Advanced Valuation Insights
This section examines the relationship between Eastwood Bio-Medical Canada Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2961.32 |
| Latest Market Cap to Assets Ratio | 409.34 |
| Asset Growth Rate (YoY) | -20.2% |
| Total Assets | CA$218.77K |
| Market Capitalization | $89.55 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Eastwood Bio-Medical Canada Inc's assets at a significant premium (409.34x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Eastwood Bio-Medical Canada Inc's assets decreased by 20.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Eastwood Bio-Medical Canada Inc (2013–2025)
The table below shows the annual total assets of Eastwood Bio-Medical Canada Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-10-31 | CA$218.77K ≈ $158.26K |
-20.24% |
| 2024-10-31 | CA$274.29K ≈ $198.42K |
-43.92% |
| 2023-10-31 | CA$489.14K ≈ $353.83K |
-16.32% |
| 2022-10-31 | CA$584.53K ≈ $422.84K |
-15.42% |
| 2021-10-31 | CA$691.12K ≈ $499.95K |
-25.95% |
| 2020-10-31 | CA$933.38K ≈ $675.19K |
-43.34% |
| 2019-10-31 | CA$1.65 Million ≈ $1.19 Million |
-26.80% |
| 2018-10-31 | CA$2.25 Million ≈ $1.63 Million |
-20.14% |
| 2017-10-31 | CA$2.82 Million ≈ $2.04 Million |
-13.11% |
| 2016-10-31 | CA$3.24 Million ≈ $2.35 Million |
-15.20% |
| 2015-10-31 | CA$3.82 Million ≈ $2.77 Million |
-6.17% |
| 2014-10-31 | CA$4.08 Million ≈ $2.95 Million |
+9.96% |
| 2013-10-31 | CA$3.71 Million ≈ $2.68 Million |
-- |
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more